Alpha Teknova (NASDAQ:TKNO) Issues Earnings Results

Alpha Teknova (NASDAQ:TKNO) posted its quarterly earnings results on Tuesday. The company reported ($0.11) EPS for the quarter, Zacks reports. Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. Alpha Teknova updated its FY 2025 guidance to EPS.

Alpha Teknova Stock Up 3.1 %

TKNO traded up $0.18 on Tuesday, reaching $6.04. The company’s stock had a trading volume of 1,147,962 shares, compared to its average volume of 287,440. The company has a market capitalization of $321.98 million, a price-to-earnings ratio of -8.16 and a beta of 0.34. Alpha Teknova has a fifty-two week low of $1.15 and a fifty-two week high of $10.37. The company has a quick ratio of 3.94, a current ratio of 4.73 and a debt-to-equity ratio of 0.12. The stock has a 50 day moving average of $8.32 and a two-hundred day moving average of $6.88.

Wall Street Analysts Forecast Growth

Separately, Craig Hallum initiated coverage on shares of Alpha Teknova in a research note on Monday, February 10th. They set a “buy” rating and a $12.00 target price for the company.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.